entertainment -WSS

entertainment

author：knowledge 2025-09-06 03:26:09 - browse：5

hazy pages of aetna.com layered next to each other, as shown through a kaleidoscopic glass — Adobe

CVS Health is preparing to make significant changes to its 2025 Medicare Advantage plans, which could potentially drive away 10% of its membership, the company’s chief financial officer said at an investment banking conference Tuesday.

“The goal for next year is margin over membership,” CVS CFO Tom Cowhey said at the conference, hosted by Bank of America. “Could we lose up to 10% of our existing Medicare members next year? That’s entirely possible. And that’s OK, because we need to get this business back on track.”

CVS, through its Aetna subsidiary, is the third-largest Medicare Advantage insurer, with more than 4.2 million enrollees as of April, according to the latest federal data. That means next year CVS could push out up to 420,000 older adults and people with disabilities on its Medicare Advantage plans, forcing them to choose another plan.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

WSS

Live blog: Hearing on CRISPR

The dental labor crisis is a moment of opportunity

Why did Pfizer dish out millions for a Super Bowl ad?

KalVista pill reduced swelling 'attacks' caused by genetic disease

Travis Kelce and the trap of celebrity vaccine endorsements

Readout LOUD podcast: ESMO highlights & Roivant's big deal

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

To avoid data mishandling cases, universities eye AI and other tools

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Walensky prepares to leave CDC — and Congress — behind

Biden report: The neurospychology of memory and aging

Guidelines to prevent youth baseball injuries need more muscle

What is microchimerism and how does it affect maternal health?

As demand for Covid shots wanes, Moderna seeks its next success

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Wikipedia

How digital tools helped lower hypertension in marginalized patients

Senators start work on Medicare physician payment reform

Readout LOUD podcast: How biotech is using artificial intelligence

Private equity deals in Medicare Advantage declines

Gilead might be held responsible for not developing a drug

Key Senate panel to consider PBM, drug pricing reform package

hotspot

leisure time

leisure time

leisure time